西点药业：关于回购公司股份方案的公告

Group 1 - The company, West Point Pharmaceutical, announced a plan to repurchase its issued A-shares using self-owned and/or self-raised funds through centralized bidding [2] - The total amount for the repurchase is set to be no less than RMB 25 million and no more than RMB 50 million [2] - The repurchase price will not exceed RMB 42.00 per share [2] - The implementation period for the repurchase is within 12 months from the date the board of directors approves the plan [2]